CAS 706779-91-1 appears in our catalog under these names: Pimavanserin, Pimavanserin, 95%, Pimavanserin/ 97.84% (existing batch purity), N-[(4-Fluorophenyl)methyl]-N-(1-methyl-4-piperidinyl)-N''-[[4-(2-methylpropoxy)phenyl]methyl]urea, 98%, 98%, Pimavanserin (Standard), 99.71%. Offered by: GLPBio, Combi-blocks, Chemat Brand, TRC, Mikromol. Available pack sizes: 1mg, 1g, 250mg, on request, 100mg, 10mg, 25mg, 50mg.
Pimavanserin is a member of the class of ureas in which three of the four hydrogens are replaced by 4-fluorobenzyl, 1-methylpiperidin-4-yl, and 4-(isopropyloxy)benzyl groups. An atypical antipsychotic that is used (in the form of its tartrate salt) for treatment of hallucinations and delusions associated with Parkinson's disease. It has a role as a 5-hydroxytryptamine 2A receptor inverse agonist, an antipsychotic agent and a serotonergic antagonist. It is a member of piperidines, an aromatic ether, a member of ureas, a tertiary amino compound and a member of monofluorobenzenes. It is a conjugate base of a pimavanserin(1+).
Source: ChEBI
| Molecular formula | C25H34FN3O2 |
|---|---|
| Molecular weight | 427.6 g/mol |
| IUPAC name | 1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea |
| InChIKey | RKEWSXXUOLRFBX-UHFFFAOYSA-N |
| SMILES | CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C |
Computed by PubChem (NCBI)